What is the equivalent dose of valsartan (Angiotensin II receptor antagonist) for a patient taking 100 mg of losartan (Angiotensin II receptor antagonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Losartan to Valsartan Dose Conversion

The equivalent dose of valsartan for a patient taking 100 mg of losartan is 160 mg of valsartan daily. 1

Dose Equivalence Based on Guidelines

According to the 2022 AHA/ACC/HFSA guideline for the management of heart failure, the following dosing information is provided for these angiotensin II receptor blockers (ARBs):

  • Losartan: Initial dose 25-50 mg once daily; target dose 50-150 mg once daily; mean dose achieved in clinical trials 129 mg total daily 1
  • Valsartan: Initial dose 20-40 mg once daily; target dose 160 mg twice daily; mean dose achieved in clinical trials 254 mg total daily 1

Conversion Rationale

The conversion from losartan to valsartan should consider several factors:

  1. Relative potency: Based on the target doses in heart failure guidelines, valsartan has a higher target dose (320 mg daily) compared to losartan (50-150 mg daily), suggesting that valsartan requires higher doses to achieve similar clinical effects 1

  2. Clinical trial evidence: In comparative studies, valsartan 160 mg daily has shown comparable or slightly better antihypertensive efficacy than losartan 100 mg daily 2

  3. Pharmacokinetic differences: Valsartan has different pharmacokinetic properties than losartan, with valsartan requiring higher doses to achieve similar clinical effects 3

Specific Conversion Algorithm

When converting from losartan 100 mg to valsartan:

  1. Start with valsartan 160 mg once daily
  2. Monitor blood pressure response after 2-4 weeks
  3. If needed, titrate valsartan up to the maximum dose of 320 mg daily (given as 160 mg twice daily) for optimal blood pressure control or heart failure management 1, 4

Important Clinical Considerations

  • Heart failure patients: In heart failure management, higher doses of valsartan (up to 320 mg daily given as 160 mg twice daily) may be needed for optimal outcomes 1

  • Blood pressure monitoring: Close monitoring of blood pressure is essential when switching between ARBs, as individual responses may vary 4

  • Renal function: Monitor renal function and serum potassium when switching between ARBs, especially in patients with compromised renal function 4

  • Timing of administration: Valsartan can be administered once daily for hypertension, but twice-daily dosing (160 mg twice daily) is recommended for heart failure management 1

Common Pitfalls to Avoid

  • Underdosing: Starting with too low a dose of valsartan may result in inadequate blood pressure control or suboptimal heart failure management

  • Lack of monitoring: Failing to monitor blood pressure and renal function after switching medications

  • Forgetting comorbidities: Heart failure patients may require higher doses of valsartan compared to those with hypertension alone 1, 4

  • Pregnancy considerations: Both losartan and valsartan are contraindicated in pregnancy 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical advantage of valsartan.

Cardiology, 1999

Guideline

Hypertension and Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.